The analysis found GLP-1 drugs slashed the risk of alcohol-related hospital admission by 26% compared with other diabetes medicines

GLP-1 receptor agonists are among the active ingredients in so-called weight-loss injections. Originally developed to treat type 2 diabetes, they are now also used to treat severe…

Weight-loss jabs such as Wegovy and Mounjaro have been linked to a sharp decline in the number of people admitted to hospital for alcohol-use disorder.